Publications

• Abanyie FA, Valice E, Delli Carpini KW, Gray EB, McAuliffe I, Chin-Hong PV, Handali S, Montgomery, SP, Huprikar S. Organ Donor Screening Practices for Strongyloides stercoralis Infection among US Organ Procurement OrganizationsExternal. Transplant Infectious Disease. 2018: 20(3): e12865.
• Page W, Judd J, Bradbury RS. The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action. Trop Med Infect Dis 2018, 3(2), 53
• Jourdan PM, Lamberton P, Fenwick A, Addiss DG. Soil-transmitted helminth infections. Lancet 2018; 391:252-65.
• Khushman M, Morris MI, Diaz L, Goodman M, Pereira D, Fuller K, Garcia-Buitrago M, Moshiree B, Zelaya S, Nayer A, Benjamin CL, and Komanduri KV. Syndrome of Inappropirate Anti-Diuretic Hormone Secretion Secondary to Strongyloides stercoralis Infection in an Allogeneic Stem Cell Transplant Patient: A Case Report and Literature Review. Transplantation Proceedings. Vol 49, Issue 2, March 2017. p.373-377.
• Cesar Henriquez-Camacho, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016 Jan 18; (1): 1-50.
• Elise M. O’Connell and Thomas B. Nutman. Molecular Diagnostics for Soil-Transmitted Helminths. Am J Trop Med Hyg, 95(3), 2016, p.508-513.
• Abanyie FA, Gray EB, Delli Carpini KW, Yanofsky A, McAuliffe I, Rana M, Chin-Hong PV, Barone CN, Davis JL, et al., Donor-Derived Strongyloides stercoralis Infection in Solid Organ Transplant Recipients in the United States, 2009-2013External Am J Transplant 15(5):1369–75.
• Le M, Ravin K, Hasan A, Clauss H, Muchant DG, Pasko JK, Cipollina G, Abanyie F, Montgomery SP, Loy M, Ahmed M, Mathur M, Chokkalingam Mani B, Mehr J, Kotru A, Varma C, Maksimak M, Schultz M, Obradovic G, Alvarez R, Toyoda Y, Birkenbach M, Brunner E, Nelson J. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. Am J Transplant. 2014 May;14(5):1199-206.
• Krolewiecki, et al. A Public Health Response against Strongyloides stercoralis: Time to Look at Soil-Transmitted Helminthiasis in Full. PLOS Negl Trop Dis 7(5): e2165.
• Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012 Aug; 25(4):458-63.
• Hamilton KW, Abt PL, Rosenbach MA et al. Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation 2011; 91(9):1019-24.
• Fusco DN, Downs JA, Satlin MJ, et al. Non-oral treatment with ivermectin for disseminated strongyloidiasis. Am J Trop Med Hyg 2010;83(4):879-83.
• Page W, Dempsey K, McCarthy J. Utility of serological follow-up of chronic strongyloidiasis after antihelminthic chemotherapy. Transactions of the Royal Society of Tropical Medicine and Hygiene (2006) 100, 1056-1062.
• Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs B. Parasite-specific IgG Response and Peripheral Blood Eosinophil Count Following Albendazole Treatment for Presumed Chronic Strongyloidiasis. J Travel Med 2006; 13: 84-91.
• Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;17(1):208-17.
• Tarr PE, Miele PS, Pere KS, et al., Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003:68(4):453-5.
• Loutfy MR, Wilson M, Keystone JS, and Kain KC. Serology and Eosinophil Count in the Diagnosis and Management of Strongyloidiasis in a Non-Endemic Area. Am J Trop Med Hyg, 66(6), 2002, pp. 749-752.

Back To Top